chartexchange

Molecular Designs Secures First FDA Clearance for Respiratory Test

Securities.io | Nov 13, 2026 12:27 PM EST

Molecular Designs announced on November 13, 2026 that the US Food and Drug Administration (FDA) had granted 510(k) clearance K262789 for its SimplicityDx Panel FluA/FluB/RSV, the company’s first FDA-cleared assay. The multiplex real-time RT-PCR test qualitatively detects and differentiates influenza A, influenza B and respiratory syncytial virus (RSV) RNA in anterior nasal swab specimens from individuals with signs and symptoms of respiratory tract infection. The panel is for prescription use…

Read original article